https://orcid.org/0000-0001-7539-505X
Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sandra Arvidsson, Robert Eriksson, Intissar Anan & Victoria Heldestad. (2023) Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis. Annals of Medicine 55:2.
Read now
Read now
A Di Paolantonio, A Romano, V Guglielmino, F Vitali, MA Sciarrone, G Bisogni, T Verdolotti, M Maceroni, AM Minnella & M Luigetti. (2023) Central nervous system involvement in two siblings affected by hereditary transthyretin amyloidosis 30 years after liver transplantation: a model for gene-silencing therapies. Neurological Research 45:8, pages 773-778.
Read now
Read now
Angela Romano, Valeria Guglielmino, Andrea Di Paolantonio, Giulia Bisogni, Mario Sabatelli, Giacomo Della Marca, Angelo Maria Minnella, Martina Maceroni, Simone Bellavia, Irene Scala, Eleonora Sabatelli, Eleonora Rollo & Marco Luigetti. (2022) Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience. Amyloid 29:4, pages 270-275.
Read now
Read now
Zornitsa Pavlova, Stayko Sarafov, Tihomir Todorov, Andrey Kirov, Teodora Chamova, Mariana Gospodinova, Ivailo Tournev, Vanyo Mitev & Albena Todorova. (2021) Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria. Amyloid 28:4, pages 219-225.
Read now
Read now
Lucia Galan, Juan Gonzalez-Moreno, José Manuel Martínez-Sesmero, Francisco Muñoz-Beamud, Maria Dolores Santos-Rubio, Diana Tran, Paul Lebeau, Michelle Stewart, Pablo Mallaina, Patricia Tarilonte, Carmen Peral & Mark H Rozenbaum. (2021) Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 21:5, pages 967-973.
Read now
Read now
Thibaud Damy, Isabel Conceição, Pablo García-Pavía, Julian Gillmore, Ravi Jandhyala, Jan Sabbat, Jonas Wixner & Teresa Coelho. (2021) A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosis. Amyloid 28:3, pages 189-198.
Read now
Read now
Articles from other publishers (46)
Marcus Vinicius Pinto, Marcondes Cavalcante FrançaJrJr, Marcus Vinicius Magno Gonçalves, Marcela Câmara Machado-Costa, Marcos Raimundo Gomes de Freitas, Francisco de Assis Aquino Gondim, Carlo Domenico Marrone, Alberto Rolim Muro Martinez, Carolina Lavigne Moreira, Osvaldo J. M. Nascimento, Anna Paula Paranhos Covaleski, Acary Souza Bulle de Oliveira, Camila Castelo Branco Pupe, Marcia Maria Jardim Rodrigues, Francisco Tellechea Rotta, Rosana Herminia Scola, Wilson MarquesJrJr & Márcia Waddington-Cruz. (2023) Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition. Arquivos de Neuro-Psiquiatria 81:03, pages 308-321.
Crossref
Crossref
Inés Asunción Losada-López, Solange Kapetanovic-García, Teresa Sevilla-Mantecón & Francisco Muñoz-Beamud. (2023) Follow-up regimens for carriers of hereditary transthyretin variants. Medicina Clínica 160:5, pages 213-217.
Crossref
Crossref
Inés Asunción Losada-López, Solange Kapetanovic-García, Teresa Sevilla-Mantecón & Francisco Muñoz-Beamud. (2023) Follow-up regimens for carriers of hereditary transthyretin variants. Medicina Clínica (English Edition) 160:5, pages 213-217.
Crossref
Crossref
Sachin Kumar, Vijay Kumar Bhardwaj, Rahul Singh & Rituraj Purohit. (2023) Structure restoration and aggregate inhibition of V30M mutant transthyretin protein by potential quinoline molecules. International Journal of Biological Macromolecules 231, pages 123318.
Crossref
Crossref
Carmen Adella Sirbu, Raluca Ivan, Francois Jerome Authier, Florentina Ionita-Radu, Dragos Catalin Jianu, Octavian Vasiliu, Ciprian Constantin & Sorin Tuță. (2023) Orphan Drugs in Neurology—A Narrative Review. Journal of Personalized Medicine 13:3, pages 420.
Crossref
Crossref
Md. Adil Shaharyar, Rudranil Bhowmik, Fahad A. Al-Abbasi, Shareefa A. AlGhamdi, Amira M. Alghamdi, Arnab Sarkar, Imran Kazmi & Sanmoy Karmakar. (2023) Vaccine Formulation Strategies and Challenges Involved in RNA Delivery for Modulating Biomarkers of Cardiovascular Diseases: A Race from Laboratory to Market. Vaccines 11:2, pages 241.
Crossref
Crossref
Martina Maceroni, Benedetto Falsini, Marco Luigetti, Angela Romano, Valeria Guglielmino, Romina Fasciani, Giorgio Placidi, Elena D’Agostino, Paola Sasso, Stanislao Rizzo & Angelo Maria Minnella. (2023) Ocular Morpho-Functional Evaluation in ATTRv Pre-Symptomatic Carriers: A Case Series. Diagnostics 13:3, pages 359.
Crossref
Crossref
Sonia Vicenty-Rivera & Ingrid Bonilla-Mercado. 2023. New Insights on Cardiomyopathy [Working Title]. New Insights on Cardiomyopathy [Working Title].
Kristina Mouksian, Jessica Ammon, Drenda Pullen, Qiuhua Zhang, Neeraja Yedlapati & John Lynn Jefferies. (2023) Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female. Journal of Cardiovascular Development and Disease 10:1, pages 13.
Crossref
Crossref
Konstantinos I. Tsamis, Dimitrios Mytilinaios, Michael Heneghan, Julian D. Gillmore, Janet A. Gilbertson, Sotirios Giannopoulos, Ioannis Sarmas & Spyridon Konitsiotis. (2022) Treatment of acquired transthyretin amyloidosis in domino liver transplantation. Clinical Transplantation 37:1.
Crossref
Crossref
Hangyu Wu, Aniket Wahane, Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, SooWan Lee, Evan M. McCabe, Theodore P. Rasmussen, Raman Bahal, Xiao-bo Zhong & José E. Manautou. (2022) Nephrotoxicity of marketed antisense oligonucleotide drugs. Current Opinion in Toxicology 32, pages 100373.
Crossref
Crossref
Maria M. Picken. (2022) Current Understanding of Systemic Amyloidosis and Underlying Disease Mechanisms. The American Journal of Cardiology 185, pages S2-S10.
Crossref
Crossref
Marco Luigetti, Andrea Di Paolantonio, Valeria Guglielmino & Angela Romano. (2022) Cutaneous silent period in ATTRv carriers: a possible early marker of nerve damage?. Neurological Sciences 43:12, pages 6979-6982.
Crossref
Crossref
Fiore Manganelli, Gian Maria Fabrizi, Marco Luigetti, Paola Mandich, Anna Mazzeo & Davide Pareyson. (2020) Hereditary transthyretin amyloidosis overview. Neurological Sciences 43:S2, pages 595-604.
Crossref
Crossref
Marco Luigetti, Valeria Guglielmino, Angela Romano, Maria Ausilia Sciarrone, Francesca Vitali, Viola D’Ambrosio & Pietro Manuel Ferraro. (2022) Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers. Genes 13:12, pages 2236.
Crossref
Crossref
Mário Sousa. (2022) Preimplantation genetic testing for familial amyloid polyneuropathy. Reproductive Health 19:1.
Crossref
Crossref
Man Amanat, Christina L. Nemeth, Amena Smith Fine, Doris G. Leung & Ali Fatemi. (2022) Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics 14:11, pages 2389.
Crossref
Crossref
Heena Chauhan, Pawan Gupta & Bhagawati Saxena. 2022. Alzheimer's Disease. Alzheimer's Disease.
Tomáš Bauer. (2022) Family with hereditary transthyretin amyloidosis - case report. Neurologie pro praxi 23:5, pages 406-411.
Crossref
Crossref
Chafic Karam, Duncan Brown, Min Yang, Nicolae Done, Jing Jing Zhu, Alexandra Greatsinger, Ana Bozas, Montserrat Vera‐Llonch & James Signorovitch. (2022)
Long‐term
treatment effects of inotersen on
health‐related
quality of life in patients with
hATTR
amyloidosis with polyneuropathy: Analysis of the
open‐label
extension of the
NEURO‐TTR
trial
. Muscle & Nerve 66:4, pages 438-446.
Crossref
Crossref
Susan J. Keam. (2022) Vutrisiran: First Approval. Drugs 82:13, pages 1419-1425.
Crossref
Crossref
Scott Arno & Jennifer Cowger. (2021) The genetics of cardiac amyloidosis. Heart Failure Reviews 27:5, pages 1485-1492.
Crossref
Crossref
Chafic Karam, Duncan Brown, Min Yang, Nicolae Done, Ibou Dieye, Ana Bozas, Montserrat Vera Llonch & James Signorovitch. (2022)
Factors associated with increased
health‐related
quality‐of‐life benefits in hereditary transthyretin amyloidosis polyneuropathy patients treated with inotersen
. Muscle & Nerve 66:3, pages 319-328.
Crossref
Crossref
Marco Luigetti, Valeria Guglielmino, Marina Romozzi, Angela Romano, Andrea Di Paolantonio, Giulia Bisogni, Eleonora Sabatelli, Anna Modoni, Mario Sabatelli, Serenella Servidei & Mauro Lo Monaco. (2022) Nerve Conduction Studies of Dorsal Sural Nerve: Normative Data and Its Potential Application in ATTRv Pre-Symptomatic Subjects. Brain Sciences 12:8, pages 1037.
Crossref
Crossref
Marco Luigetti, Giovanni Antonini, Andrea Di Paolantonio, Luca Gentile, Marina Grandis, Luca Leonardi, Alessandro Lozza, Fiore Manganelli, Anna Mazzeo, Roberta Mussinelli, Filomena My, Laura Obici, Elena Maria Pennisi, Marina Romozzi, Massimo Russo, Mario Sabatelli, Alessandro Salvalaggio, Matteo Tagliapietra & Stefano Tozza. (2022) Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy. European Journal of Neurology 29:7, pages 2148-2155.
Crossref
Crossref
Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, Hangyu Wu, Theodore P. Rasmussen, Raman Bahal, Xiao-bo Zhong & José E. Manautou. (2022) Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs. Drug Metabolism and Disposition 50:6, pages 879-887.
Crossref
Crossref
Julian D. Gillmore, Mary M. Reilly, Caroline J. Coats, Rob Cooper, Helen Cox, Mark R. E. Coyne, Andrew J. Green, Ruth McGowan, William E. Moody & Philip N. Hawkins. (2022) Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK. Advances in Therapy 39:6, pages 2292-2301.
Crossref
Crossref
Maja Ostojic, Sukhraj S Gill, Jose David Avila & Brendan J Carry. (2022) A Rare Case of I127V Heterozygous Transthyretin Amyloidosis With Atypical Transthoracic Echocardiogram Findings Presenting As Upper Extremity Sensorimotor Polyneuropathy. Cureus.
Crossref
Crossref
Daniele Severi, Francesco Aruta, Aniello Iovino, Emanuele Spina, Maria Nolano, Fiore Manganelli & Stefano Tozza. (2022) Can we identify hereditary TTR amyloidosis by the screening of carpal tunnel syndrome patients?. Neurological Sciences 43:5, pages 3435-3438.
Crossref
Crossref
Marco Luigetti, Andrea Di Paolantonio, Valeria Guglielmino, Angela Romano, Salvatore Rossi, Andrea Sabino, Serenella Servidei, Mario Sabatelli & Guido Primiano. (2022) Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience. Neurological Sciences 43:4, pages 2845-2848.
Crossref
Crossref
José Castro, Bruno Miranda, Isabel de Castro & Isabel Conceição. (2021) Changes in nerve conduction studies predate clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis. European Journal of Neurology 29:3, pages 826-832.
Crossref
Crossref
Monica Alcantara, Michelle M. Mezei, Steven K. Baker, Ari Breiner, Priya Dhawan, Amanda Fiander, Nowell M. Fine, Christopher Hahn, Hans D. Katzberg, Shahin Khayambashi, Rami Massie, Genevieve Matte, Brendan Putko, Zaeem Siddiqi, Diego Delgado & Vera Bril. (2021) Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 49:1, pages 7-18.
Crossref
Crossref
Aaron Yarlas, Andrew Lovley, Duncan Brown, Mark Kosinski & Montserrat Vera-Llonch. (2021) Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study. Journal of Neurology 269:1, pages 323-335.
Crossref
Crossref
Montserrat Vera-Llonch, Sheila R. Reddy, Eunice Chang, Marian H. Tarbox & Michael Pollock. (2021) The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Guido Primiano, Tommaso Verdolotti, Gabriella D’Apolito, Andrea Di Paolantonio, Valeria Guglielmino, Angela Romano, Gabriele Lucioli, Marco Luigetti & Serenella Servidei. (2021) Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study. Genes 12:11, pages 1786.
Crossref
Crossref
Pranav Chandrashekar, Laith Alhuneafat, Meghan MannelloLana Al-Rashdan, Morris M. Kim, Jason Dungu, Kevin Alexander & Ahmad Masri. (2021)
Prevalence and Outcomes of p.Val142Ile
TTR
Amyloidosis Cardiomyopathy: A Systematic Review
. Circulation: Genomic and Precision Medicine 14:5.
Crossref
Crossref
Pietro Manuel Ferraro, Viola D’Ambrosio, Andrea Di Paolantonio, Valeria Guglielmino, Paolo Calabresi, Mario Sabatelli & Marco Luigetti. (2021) Renal Involvement in Hereditary Transthyretin Amyloidosis: An Italian Single-Centre Experience. Brain Sciences 11:8, pages 980.
Crossref
Crossref
Rita Vieira, Ana Marta, Ana Figueiredo, Rita Reis, Isabel Sampaio & Maria J Menéres. (2021) Transscleral Cyclophotocoagulation in Familial Amyloidotic Polyneuropathy Secondary Glaucoma after Ahmed Valve Implantation: A Case Series Study. Journal of Current Glaucoma Practice 15:1, pages 32-35.
Crossref
Crossref
Stanley T. Crooke, Xue-hai Liang, Rosanne M. Crooke, Brenda F. Baker & Richard S. Geary. (2021) Antisense drug discovery and development technology considered in a pharmacological context. Biochemical Pharmacology 189, pages 114196.
Crossref
Crossref
Stanley T. Crooke, Brenda F. Baker, Rosanne M. Crooke & Xue-hai Liang. (2021) Antisense technology: an overview and prospectus. Nature Reviews Drug Discovery 20:6, pages 427-453.
Crossref
Crossref
Marco Luigetti, Valeria Guglielmino, Giovanni Antonini, Carlo Casali, Marco Ceccanti, Maria Grazia Chiappini, Laura De Giglio, Vincenzo Di Lazzaro, Antonio Di Muzio, Mariangela Goglia, Maurizio Inghilleri, Luca Leonardi, Roberto Massa, Elena Maria Pennisi, Antonio Petrucci, Emanuela Proietti, Marianna Rispoli, Mario Sabatelli & Marco Di Girolamo. (2021) ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country. Genes 12:6, pages 829.
Crossref
Crossref
Marco Luigetti & Serenella Servidei. (2021) Patisiran in hereditary transthyretin-mediated amyloidosis. The Lancet Neurology 20:1, pages 21-23.
Crossref
Crossref
Antonella De Lillo, Gita A. Pathak, Flavio De Angelis, Marco Di Girolamo, Marco Luigetti, Mario Sabatelli, Federico Perfetto, Sabrina Frusconi, Dario Manfellotto, Maria Fuciarelli & Renato Polimanti. (2020) Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis. Clinical Epigenetics 12:1.
Crossref
Crossref
M. Grandis, L. Obici, M. Luigetti, C. Briani, F. Benedicenti, G. Bisogni, M. Canepa, F. Cappelli, C. Danesino, G. M. Fabrizi, S. Fenu, G. Ferrandes, C. Gemelli, F. Manganelli, A. Mazzeo, L. Melchiorri, F. Perfetto, L. G. Pradotto, P. Rimessi, G. Tini, S. Tozza, L. Trevisan, D. Pareyson & P. Mandich. (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Sheila R. Reddy, Eunice Chang, Marian H. Tarbox, Michael S. Broder, Ryan S. Tieu, Spencer Guthrie, Montserrat Vera-Llonch & Michael R. Pollock. (2020) The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data. Neurology and Therapy 9:2, pages 473-482.
Crossref
Crossref
Marco Luigetti, Marina Romozzi, Giulia Bisogni, Davide Cardellini, Tiziana Cavallaro, Andrea Di Paolantonio, Gian Maria Fabrizi, Silvia Fenu, Luca Gentile, Marina Grandis, Gianluca Marucci, Sara Massucco, Anna Mazzeo, Davide Pareyson, Angela Romano, Massimo Russo, Angelo Schenone, Matteo Tagliapietra, Stefano Tozza, Giuseppe Vita & Mario Sabatelli. (2020) hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers. Brain Sciences 10:11, pages 780.
Crossref
Crossref